Family Support Intervention in Intensive Care Units
FICUS
A Multi-center, Cluster Randomized Superiority Trial of a Guideline-based Family Support Intervention in Intensive Care Units
1 other identifier
interventional
885
1 country
12
Brief Summary
Background: Family members of critically ill patients face considerable uncertainty and distress during their close other's intensive care unit (ICU) stay, with about 20-60% of family members experiencing post-traumatic distress post-ICU. Guidelines recommend structured family inclusion, communication, and support, but the existing evidence base around protocolized family support interventions is modest and requires substantiation. Methods: To test the clinical effectiveness and explore the implementation of a multicomponent, nurse-led family support intervention in ICUs, the investigators will undertake a parallel, cluster-randomized, controlled, multicenter superiority hybrid-type 1 trial. The trial will include eight clusters (ICUs) per study arm, with a projected total sample size of 896 family members of adult, critically ill patients treated in the German-speaking part of Switzerland. The trial targets family members of critically ill patients with an expected ICU stay of 48 hours or longer. Families in the control arm will receive usual care. Families in the intervention arm, in addition to usual care, will receive a family support intervention consisting of specialist nurse support along the patient pathway at defined time-points, including follow-up care, and nurse-coordinated liaison and structured, interprofessional communication by the ICU team. The primary study endpoint is quality of family care, operationalized as family members' satisfaction with ICU care at discharge. Secondary endpoints include quality of communication and nurse support, family management of critical illness (functioning, resilience), and family members' mental health (well-being, psychological distress) measured at admission, discharge, and after three, six, and twelve months. Data of all participants, regardless of protocol adherence, will be analyzed using linear mixed-effects models, with the individual participant as the unit of inference. Discussion: The FICUS trial will establish the effectiveness of the family support intervention and generate knowledge of its implementability. Both types of evidence are necessary to determine whether the intervention works as intended in clinical practice and whether an effective intervention could be scaled-up to other ICUs. The study findings will make a significant contribution to the current body of knowledge on effective ICU care that promotes family participation and well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2022
CompletedFirst Posted
Study publicly available on registry
March 15, 2022
CompletedStudy Start
First participant enrolled
May 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 2, 2025
June 1, 2025
1.9 years
February 20, 2022
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Satisfaction with Care (Quality of Family Care)
Quality of family care in ICU is operationalized as family satisfaction with ICU care, and measured with the Family Satisfaction in ICU questionnaire (FS-ICU-24R, German version). The FS-ICU-24R is a well-established instrument that assesses satisfaction with care (16 items) and satisfaction with involvement in decision-making (ten items). Its scores range from 0-100 with 100 indicating maximal satisfaction.
Assessed no earlier than 24 hours prior to and no later than 14 days following the discharge of the patient from ICU.
Secondary Outcomes (10)
Quality of Communication (Quality of Family Care)
Assessed no earlier than 24 hours prior to and no later than 14 days following the discharge of the patient from ICU.
Nurse Support (Quality of Family Care)
Assessed no earlier than 24 hours prior to and no later than 14 days following the discharge of the patient from ICU.
Family Functioning (Family Management)
Assessed within 96 hours after the admission of the patient to ICU, at the discharge from ICU (between 24 hours prior and 14 days after), 3 months (76-104 days), 6 months (166-194 days), and 12 months (351-379 days) after the discharge from ICU.
Family Resilience (Family Management)
Assessed within 96 hours after the admission of the patient to ICU, at the discharge from ICU (between 24 hours prior and 14 days after), 3 months (76-104 days), 6 months (166-194 days), and 12 months (351-379 days) after the discharge from ICU.
Satisfaction with Life (Subjective Well-Being)
Assessed within 96 hours after the admission of the patient to ICU, at the discharge from ICU (between 24 hours prior and 14 days after), 3 months (76-104 days), 6 months (166-194 days), and 12 months (351-379 days) after the discharge from ICU.
- +5 more secondary outcomes
Study Arms (2)
Family Support Intervention
OTHERFamilies in the intervention group receive the Family Support Intervention in addition to usual care
Usual Care
NO INTERVENTIONFamilies in the control group will receive usual care.
Interventions
In addition to usual care, families in the intervention group will receive (1) specialist nurse support along the patient pathway at defined time-points, from admission to discharge including follow-up care, and (2) nurse-coordinated liaison and structured, interprofessional communication by the ICU team. The intervention is grounded in a family systems approach and guideline-based strategies for family engagement in the ICU and has been pilot-tested in one ICU.
Eligibility Criteria
You may qualify if:
- Expected length of stay in ICU ≥48 hours, as predicted by the intaking ICU clinician (physician or nurse) at admission.
- Life-threatening condition with a high risk of death or long-lasting functional impairment.
- High risk of prolonged mechanical ventilation (\>24 hours).
- Primary support person of the patient.
- Able to complete family-reported outcome measures (questionnaires) in German language.
- Age ≥18 years.
- Signed informed consent form.
You may not qualify if:
- Preexisting declined general consent.
- ICU stay \<24 hours.
- Cognitive inability to understand the study or complete the questionnaire as appraised by clinicians and / or study recruitment staff.
- Inability to complete baseline data collection within the required timeframe after admission / study enrollment (Calvert et al., 2018).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rahel Naeflead
- Swiss National Science Foundationcollaborator
Study Sites (12)
Cantonal Hospital Winterthur
Winterthur, Canton of Zurich, 8400, Switzerland
Cantonal Hospital Baden
Baden, Switzerland
Lindenhof-Hospital
Bern, Switzerland
University Hospital Bern - Inselspital
Bern, Switzerland
Cantonal Hospital Graubünden
Chur, Switzerland
Spital Thurgau AG, Cantonal Hospital Frauenfeld
Frauenfeld, Switzerland
Lucerne Cantonal Hospital
Lucerne, Switzerland
Solothurn Hospitals AG, Cantonal Hospital Olten
Olten, Switzerland
Cantonal Hospital St. Gallen
Sankt Gallen, Switzerland
Hospital Thun
Thun, Switzerland
University Hospital Zurich
Zurich, 8091, Switzerland
Hirslanden Clinic Zurich
Zurich, Switzerland
Related Publications (7)
Oesch S, Verweij L, Riguzzi M, Finch T, Naef R. Exploring Implementation Processes of a Multicomponent Family Support Intervention in Intensive Care Units (FICUS) Study: A Mixed-Methods Process Evaluation. J Adv Nurs. 2025 Nov;81(11):7245-7265. doi: 10.1111/jan.16544. Epub 2024 Oct 18.
PMID: 39422155BACKGROUNDVerweij L, Oesch S, Naef R. Tailored implementation of the FICUS multicomponent family support intervention in adult intensive care units: findings from a mixed methods contextual analysis. BMC Health Serv Res. 2023 Dec 1;23(1):1339. doi: 10.1186/s12913-023-10285-1.
PMID: 38041092BACKGROUNDWalker SP, Gaskin P, Powell CA, Bennett FI, Forrester TE, Grantham-McGregor S. The effects of birth weight and postnatal linear growth retardation on blood pressure at age 11-12 years. J Epidemiol Community Health. 2001 Jun;55(6):394-8. doi: 10.1136/jech.55.6.394.
PMID: 11350995BACKGROUNDNaef R, Filipovic M, Jeitziner MM, von Felten S, Safford J, Riguzzi M, Rufer M. A multicomponent family support intervention in intensive care units: study protocol for a multicenter cluster-randomized trial (FICUS Trial). Trials. 2022 Jun 27;23(1):533. doi: 10.1186/s13063-022-06454-y.
PMID: 35761343BACKGROUNDOesch S, Verweij L, Clack L, Finch T, Riguzzi M, Naef R. Implementation of a multicomponent family support intervention in adult intensive care units: study protocol for an embedded mixed-methods multiple case study (FICUS implementation study). BMJ Open. 2023 Aug 8;13(8):e074142. doi: 10.1136/bmjopen-2023-074142.
PMID: 37553195BACKGROUNDNaef R, Jeitziner MM, Riguzzi M, von Felten S, Verweij L, Rufer M, Safford J, Sutter S, Bergmann-Kipfer B, Betschart U, Boltshauser S, Brulisauer N, Brunner C, Buhler PK, Burkhalter H, Dullenkopf A, Heise A, Hertler B, Hoffmann JE, Karde C, Keller Y, Kohler S, Lussmann F, Massarotto P, Moser M, Pietsch U, Segalada DL, Siegrist E, Steiger P, Ruch N, von Dach C, Wenzler MS, Wiegand J, Zante B, Filipovic M; FICUS Study Group. Nurse-Led Family Support Intervention for Families of Critically Ill Patients: The FICUS Cluster Randomized Clinical Trial. JAMA Intern Med. 2025 Sep 1;185(9):1138-1149. doi: 10.1001/jamainternmed.2025.3406.
PMID: 40720110DERIVEDvon Felten S, Filipovic M, Jeitziner MM, Verweij L, Riguzzi M, Naef R. Multicomponent family support intervention in intensive care units: statistical analysis plan for the cluster-randomized controlled FICUS trial. Trials. 2024 Aug 28;25(1):568. doi: 10.1186/s13063-024-08351-y.
PMID: 39198900DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rahel Naef, PhD, RN
University of Zurich
- PRINCIPAL INVESTIGATOR
Miodrag Filipovic, MD
Cantonal Hospital of St. Gallen
- PRINCIPAL INVESTIGATOR
Marie-Madlen Jeitziner, PhD, RN
University Hospital Bern, Inselspital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor of Implementation Science in Nursing
Study Record Dates
First Submitted
February 20, 2022
First Posted
March 15, 2022
Study Start
May 12, 2022
Primary Completion
March 31, 2024
Study Completion
December 31, 2024
Last Updated
July 2, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share